Partner: Cathal J Hannan


Recent publications
1.Jones A. P., Haley M. J., Meadows M. H., Gregory G. E., Hannan C. J., Simmons A. K., Bere L. D., Lewis D. G., Pedro O., Smith M. J., King A. T., Evans D. Gareth R., Paszek P., Brough D., Pathmanaban O. N., Couper K. N., Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannoma, Nature Communications, ISSN: 2041-1723, DOI: 10.1038/s41467-025-57586-z, Vol.16, pp.2944-1-18, 2025
Abstract:

NF2-related Schwannomatosis (NF2 SWN) is a rare disease characterised by the growth of multiple nervous system neoplasms, including bilateral vestibular schwannoma (VS). VS tumours are characterised by extensive leucocyte infiltration. However, the immunological landscape in VS and the spatial determinants within the tumour microenvironment that shape the trajectory of disease are presently unknown. In this study, to elucidate the complex immunological networks across VS, we performed imaging mass cytometry (IMC) on clinically annotated VS samples from NF2 SWN patients. We reveal the heterogeneity in neoplastic cell, myeloid cell and T cell populations that co-exist within VS, and that distinct myeloid cell and Schwann cell populations reside within varied spatial contextures across characteristic Antoni A and B histomorphic niches. Interestingly, T-cell populations co-localise with tumour-associated macrophages (TAMs) in Antoni A regions, seemingly limiting their ability to interact with tumorigenic Schwann cells. This spatial landscape is altered in Antoni B regions, where T-cell populations appear to interact with PD-L1+ Schwann cells. We also demonstrate that prior bevacizumab treatment (VEGF-A antagonist) preferentially reduces alternatively activated-like TAMs, whilst enhancing CD44 expression, in bevacizumab-treated tumours. Together, we describe niche-dependent modes of T-cell regulation in NF2 SWN VS, indicating the potential for microenvironment-altering therapies for VS.

Affiliations:
Jones A. P.-other affiliation
Haley M. J.-other affiliation
Meadows M. H.-other affiliation
Gregory G. E.-other affiliation
Hannan C. J.-other affiliation
Simmons A. K.-other affiliation
Bere L. D.-other affiliation
Lewis D. G.-other affiliation
Pedro O.-other affiliation
Smith M. J.-other affiliation
King A. T.-other affiliation
Evans D. Gareth R.-other affiliation
Paszek P.-IPPT PAN
Brough D.-other affiliation
Pathmanaban O. N.-other affiliation
Couper K. N.-other affiliation
2.Gregory Grace E., Haley Michael J., Jones Adam P., Hannan C., Evans D. G., King Andrew T., Paszek P., Pathmanaban Omar N., Couper Kevin N., Brough D., Alternatively activated macrophages are associated with faster growth rate in vestibular schwannoma, Brain Communications, ISSN: 2632-1297, DOI: 10.1093/braincomms/fcae400, Vol.6, No.6, pp.1-14, 2024
Abstract:

The variability in vestibular schwannoma growth rates greatly complicates clinical treatment. Management options are limited to radiological observation, surgery, radiotherapy and, in specific cases, bevacizumab therapy. As such, there is a pressing requirement for growth restricting drugs for vestibular schwannoma. This study explored potential predictors of vestibular schwannoma growth in depth, highlighting differences between static and growing vestibular schwannoma to identify potential therapeutic targets. High-dimensional imaging was used to characterize the tumour micro-environment of four static and five growing vestibular schwannoma (indicated by volumetric change < 20% or ≥ 20% per year, respectively). Single-cell spatial information and protein expression data from a panel of 35 tumour immune-targeted antibodies identified specific cell populations, their expression profiles and their spatial localization within the tumour micro-environment. Growing vestibular schwannoma contained significantly more proliferative and non-proliferative alternatively activated tumour-associated macrophages per millimetre square compared with static vestibular schwannoma. Furthermore, two additional proliferative cell types were identified in growing and static vestibular schwannoma: transitioning monocytes and programmed cell death ligand 1 (PD-L1+) Schwann cells. In agreement, growing vestibular schwannoma was characterized by a tumour micro-environment composed of immune-enriched, proliferative neighbourhoods, whereas static vestibular schwannoma were composed of tumour-enriched, non-proliferative neighbourhoods. Finally, classically activated macrophages significantly colocalized with alternatively activated macrophages in static vestibular schwannoma, but this sequestration was reduced in growing vestibular schwannoma. This study provides a novel, spatial characterization of the immune landscape in growing vestibular schwannoma, whilst highlighting the need for new therapeutic targets that modulate the tumour immune micro-environment.

Keywords:

tumour-associated macrophage, inflammation, tumour micro-environment, vestibular schwannoma, acoustic neuroma

Affiliations:
Gregory Grace E.-other affiliation
Haley Michael J.-other affiliation
Jones Adam P.-other affiliation
Hannan C.-other affiliation
Evans D. G.-other affiliation
King Andrew T.-other affiliation
Paszek P.-IPPT PAN
Pathmanaban Omar N.-other affiliation
Couper Kevin N.-other affiliation
Brough D.-other affiliation